Insights from 2023 ASH Annual Meeting
Playback speed
10 seconds
Impact of Ibrutinib Dose Reduction on Duration of Therapy in Patients With CLL/SLL
By
Insights from 2023 ASH Annual Meeting
FEATURING
Mazyar Shadman
By
Insights from 2023 ASH Annual Meeting
FEATURING
Mazyar Shadman
338 views
December 19, 2023
Login to view comments.
Click here to Login
Leukemia